Maternal Antibody and Viral Factors in the Pathogenesis of Dengue Virus in Infants
Cameron Paul Simmonsa b✉, Tran Nguyen Bich Chaub, Trần Thi Thúyc, Nguyen Minh Tuand, Dang Minh Hoangb, Nguyen Thanh Thiend, Le Bich Liend, Nguyen Thien Quyb, Nguyen Trong Hieue, Tran Tinh Hienf, Catriona McElneag, Paul R. Youngh, Steve Whiteheadi, Nguyễn Thanh Hùngd, Jeremy Farrarb
- aOxford University Clinical Research Unit, Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam. camsimmons1@gmail.com
- bOxford University Clinical Research Unit, Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam
- cDepartment of Infectious Diseases, Children's Hospital No 2, Ho Chi Minh City, Vietnam
- dDepartment of Dengue Haemorrhagic Fever, Children's Hospital No 1, Ho Chi Minh City, Vietnam
- eDepartment of Neonatology, Hung Vuong Hospital, Ho Chi Minh City, Vietnam
- fHospital for Tropical Diseases, Ho Chi Minh City, Vietnam
- gPanbio Ltd, Sinnamon Park, Brisbane, Australia
- hSchool of Molecular and Microbial Sciences, University of Queensland, St
- iLaboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland
- ✉Corresponding author
Papers open inside SciRah from the original publisher or repository; SciRah never hosts them.
Abstract
The pathogenesis of dengue in infants is poorly understood. We postulated that dengue severity in infants would be positively associated with markers of viral burden and that maternally derived, neutralizing anti-dengue antibody would have decayed before the age at which infants with dengue presented to the hospital. In 75 Vietnamese infants with primary dengue, we found significant heterogeneity in viremia and NS1 antigenemia at hospital presentation, and these factors were independent of disease grade or continuous measures of disease severity. Neutralizing antibody titers, predicted in each infant at the time of their illness, suggested that the majority of infants (65%) experienced dengue hemorrhagic fever when the maternally derived neutralizing antibody titer had declined to <1 : 20. Collectively, these data have important implications for dengue vaccine research because they suggest that viral burden may not solely explain severe dengue in infants and that neutralizing antibody is a reasonable but not absolute marker of protective immunity in infants.
TL;DRIt is suggested that viral burden may not solely explain severe dengue in infants and that neutralizing antibody is a reasonable but not absolute marker of protective immunity in infants. (Semantic Scholar)

